Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	minus-end-directed microtubule motor activity	DNAH3 DYNC2H1 DNAH2 DNAH14	6.02e-06	18	137	4	GO:0008569
GeneOntologyMolecularFunction	dynein light intermediate chain binding	DNAH3 DYNC2H1 DNAH2 DNAH14	3.82e-05	28	137	4	GO:0051959
GeneOntologyMolecularFunction	IMP dehydrogenase activity	IMPDH1 IMPDH2	4.67e-05	2	137	2	GO:0003938
GeneOntologyMolecularFunction	phosphoglycerate kinase activity	PGK1 PGK2	4.67e-05	2	137	2	GO:0004618
GeneOntologyMolecularFunction	protein kinase A binding	WASF3 AKAP3 NBEA RYR2 CRYBG3	4.83e-05	58	137	5	GO:0051018
GeneOntologyMolecularFunction	dynein intermediate chain binding	DNAH3 DYNC2H1 DNAH2 DNAH14	1.17e-04	37	137	4	GO:0045505
GeneOntologyMolecularFunction	phosphotransferase activity, carboxyl group as acceptor	PGK1 PGK2	1.40e-04	3	137	2	GO:0016774
GeneOntologyMolecularFunction	guanyl-nucleotide exchange factor activity	MYCBP2 DOCK9 NUCB1 SH2D3C OBSCN PSD3 EIF2B1 FGD6	1.97e-04	231	137	8	GO:0005085
GeneOntologyMolecularFunction	ryanodine-sensitive calcium-release channel activity	RYR2 RYR3	2.78e-04	4	137	2	GO:0005219
GeneOntologyMolecularFunction	histone H2AX kinase activity	BAZ1B ATM	4.61e-04	5	137	2	GO:0141003
GeneOntologyMolecularFunction	calcium-induced calcium release activity	RYR2 RYR3	6.88e-04	6	137	2	GO:0048763
GeneOntologyMolecularFunction	cytoskeletal motor activity	DNAH3 DYNC2H1 DNAH2 MYO1B DNAH14	1.33e-03	118	137	5	GO:0003774
GeneOntologyMolecularFunction	microtubule motor activity	DNAH3 DYNC2H1 DNAH2 DNAH14	1.37e-03	70	137	4	GO:0003777
GeneOntologyBiologicalProcess	cilium movement	DNAH3 DYNC2H1 DNAAF4 ASH1L DNAH2 PGK2 DNAH14 TMEM232 ULK4 SPAG16 CFAP69	1.40e-06	261	137	11	GO:0003341
GeneOntologyBiologicalProcess	cilium movement involved in cell motility	DNAH3 DYNC2H1 ASH1L DNAH2 PGK2 DNAH14 TMEM232 SPAG16 CFAP69	1.15e-05	210	137	9	GO:0060294
GeneOntologyBiologicalProcess	cilium-dependent cell motility	DNAH3 DYNC2H1 ASH1L DNAH2 PGK2 DNAH14 TMEM232 SPAG16 CFAP69	1.39e-05	215	137	9	GO:0060285
GeneOntologyBiologicalProcess	cilium or flagellum-dependent cell motility	DNAH3 DYNC2H1 ASH1L DNAH2 PGK2 DNAH14 TMEM232 SPAG16 CFAP69	1.39e-05	215	137	9	GO:0001539
GeneOntologyCellularComponent	9+2 motile cilium	DNAH3 DYNC2H1 DNAH2 AKAP3 PGK2 DNAH14 TMEM232 SPAG16 CFAP69	2.80e-05	238	137	9	GO:0097729
GeneOntologyCellularComponent	ruffle	CD2AP SH2D3C PSD3 PIP5K1C ARHGAP1 PLEK FGD6 WWC1	6.55e-05	206	137	8	GO:0001726
GeneOntologyCellularComponent	cilium	EPS15 DNAH3 DYNC2H1 DNAAF4 USP9X CEP290 DNAH2 AKAP3 ARMC9 PGK2 DNAH14 GRK1 TMEM232 ULK4 SPAG16 CFAP69	2.69e-04	898	137	16	GO:0005929
GeneOntologyCellularComponent	A band	MYOM3 OBSCN CMYA5 RYR2	3.75e-04	52	137	4	GO:0031672
GeneOntologyCellularComponent	dynein complex	DNAH3 DYNC2H1 DNAH2 DNAH14	4.33e-04	54	137	4	GO:0030286
GeneOntologyCellularComponent	motile cilium	DNAH3 DYNC2H1 DNAH2 AKAP3 PGK2 DNAH14 TMEM232 SPAG16 CFAP69	5.66e-04	355	137	9	GO:0031514
GeneOntologyCellularComponent	axonemal central apparatus	SPAG16 CFAP69	6.29e-04	6	137	2	GO:1990716
GeneOntologyCellularComponent	ruffle membrane	SH2D3C PSD3 PIP5K1C PLEK WWC1	7.30e-04	108	137	5	GO:0032587
Domain	ARM-type_fold	USP9X DOCK9 TTI2 CKAP5 NBEA ZNFX1 ARMC9 RYR3 SCYL2 ULK4 ATM CFAP69 NIPBL	1.20e-06	339	136	13	IPR016024
Domain	Dynein_heavy_chain_D4_dom	DNAH3 DYNC2H1 DNAH2 DNAH14	2.54e-06	14	136	4	IPR024317
Domain	Dynein_HC_stalk	DNAH3 DYNC2H1 DNAH2 DNAH14	2.54e-06	14	136	4	IPR024743
Domain	MT	DNAH3 DYNC2H1 DNAH2 DNAH14	2.54e-06	14	136	4	PF12777
Domain	AAA_8	DNAH3 DYNC2H1 DNAH2 DNAH14	2.54e-06	14	136	4	PF12780
Domain	DHC_fam	DNAH3 DYNC2H1 DNAH2 DNAH14	3.45e-06	15	136	4	IPR026983
Domain	Dynein_heavy	DNAH3 DYNC2H1 DNAH2 DNAH14	3.45e-06	15	136	4	PF03028
Domain	Dynein_heavy_dom	DNAH3 DYNC2H1 DNAH2 DNAH14	3.45e-06	15	136	4	IPR004273
Domain	PGLYCERATE_KINASE	PGK1 PGK2	5.26e-05	2	136	2	PS00111
Domain	Phosphoglycerate_kinase_N	PGK1 PGK2	5.26e-05	2	136	2	IPR015824
Domain	-	PGK1 PGK2	5.26e-05	2	136	2	3.40.50.1270
Domain	-	PGK1 PGK2	5.26e-05	2	136	2	3.40.50.1260
Domain	PGK	PGK1 PGK2	5.26e-05	2	136	2	PF00162
Domain	Phosphoglycerate_kinase_CS	PGK1 PGK2	5.26e-05	2	136	2	IPR015911
Domain	Phosphoglycerate_kinase_C	PGK1 PGK2	5.26e-05	2	136	2	IPR015901
Domain	IMP_DH	IMPDH1 IMPDH2	5.26e-05	2	136	2	IPR005990
Domain	Dynein_heavy_dom-2	DNAH3 DYNC2H1 DNAH2	1.30e-04	14	136	3	IPR013602
Domain	DHC_N2	DNAH3 DYNC2H1 DNAH2	1.30e-04	14	136	3	PF08393
Domain	ATPase_dyneun-rel_AAA	DNAH3 DYNC2H1 DNAH2	1.30e-04	14	136	3	IPR011704
Domain	AAA_5	DNAH3 DYNC2H1 DNAH2	1.30e-04	14	136	3	PF07728
Domain	Ryanodine_rcpt	RYR2 RYR3	1.57e-04	3	136	2	IPR003032
Domain	Phosphoglycerate_kinase	PGK1 PGK2	1.57e-04	3	136	2	IPR001576
Domain	Ryanrecept_TM4-6	RYR2 RYR3	1.57e-04	3	136	2	IPR009460
Domain	RyR	RYR2 RYR3	1.57e-04	3	136	2	PF02026
Domain	RR_TM4-6	RYR2 RYR3	1.57e-04	3	136	2	PF06459
Domain	Ryan_recept	RYR2 RYR3	1.57e-04	3	136	2	IPR013333
Domain	ARM-like	USP9X TTI2 CKAP5 NBEA ARMC9 SCYL2 ULK4 CFAP69 NIPBL	1.63e-04	270	136	9	IPR011989
Domain	IMPDH	IMPDH1 IMPDH2	3.13e-04	4	136	2	PF00478
Domain	IMP_DH_GMPRt	IMPDH1 IMPDH2	3.13e-04	4	136	2	IPR001093
Domain	IMP_DH_GMP_RED	IMPDH1 IMPDH2	3.13e-04	4	136	2	PS00487
Domain	IMP_DH/GMP_Rdtase_CS	IMPDH1 IMPDH2	3.13e-04	4	136	2	IPR015875
Domain	RIH_assoc-dom	RYR2 RYR3	7.75e-04	6	136	2	IPR013662
Domain	Ins145_P3_rec	RYR2 RYR3	7.75e-04	6	136	2	PF08709
Domain	RIH_assoc	RYR2 RYR3	7.75e-04	6	136	2	PF08454
Domain	RIH_dom	RYR2 RYR3	7.75e-04	6	136	2	IPR000699
Domain	Ins145_P3_rcpt	RYR2 RYR3	7.75e-04	6	136	2	IPR014821
Domain	Ryanodine_recept-rel	RYR2 RYR3	7.75e-04	6	136	2	IPR015925
Domain	-	RYR2 RYR3	7.75e-04	6	136	2	1.25.10.30
Domain	RYDR_ITPR	RYR2 RYR3	7.75e-04	6	136	2	PF01365
Domain	-	USP9X CKAP5 ARMC9 SCYL2 ULK4 CFAP69 NIPBL	1.22e-03	222	136	7	1.25.10.10
Domain	TPR_REGION	TANC2 DNAAF4 DNAH2 CDC16 TANC1 LRP2BP	1.33e-03	165	136	6	PS50293
Domain	TPR	TANC2 DNAAF4 DNAH2 CDC16 TANC1 LRP2BP	1.33e-03	165	136	6	PS50005
Domain	DHC_N1	DYNC2H1 DNAH2	1.43e-03	8	136	2	PF08385
Domain	Dynein_heavy_dom-1	DYNC2H1 DNAH2	1.43e-03	8	136	2	IPR013594
Domain	HEAT_REPEAT	CKAP5 SCYL2 ULK4 NIPBL	1.70e-03	70	136	4	PS50077
Domain	MIR	RYR2 RYR3	2.28e-03	10	136	2	PF02815
Domain	MIR_motif	RYR2 RYR3	2.28e-03	10	136	2	IPR016093
Domain	MIR	RYR2 RYR3	2.28e-03	10	136	2	PS50919
Domain	MIR	RYR2 RYR3	2.28e-03	10	136	2	SM00472
Domain	TPR_repeat	TANC2 DNAAF4 CDC16 TANC1 LRP2BP	2.90e-03	133	136	5	IPR019734
Domain	PH_dom-like	DOCK9 OBSCN PSD3 MYO1B NBEA CMIP OSBPL1A PLEK FGD6	4.03e-03	426	136	9	IPR011993
Domain	AAA	DNAH3 DYNC2H1 DNAH2 ABCA5 NAV1	4.08e-03	144	136	5	SM00382
Domain	AAA+_ATPase	DNAH3 DYNC2H1 DNAH2 ABCA5 NAV1	4.08e-03	144	136	5	IPR003593
Domain	-	TANC2 DNAAF4 COPS2 CDC16 TANC1 LRP2BP	4.11e-03	207	136	6	1.25.40.10
Domain	PH	DOCK9 OBSCN PSD3 CMIP OSBPL1A PLEK FGD6	4.29e-03	278	136	7	SM00233
Domain	PH_DOMAIN	DOCK9 OBSCN PSD3 CMIP OSBPL1A PLEK FGD6	4.38e-03	279	136	7	PS50003
Domain	PH_domain	DOCK9 OBSCN PSD3 CMIP OSBPL1A PLEK FGD6	4.46e-03	280	136	7	IPR001849
Domain	TPR-contain_dom	TANC2 DNAAF4 CDC16 TANC1 LRP2BP	4.85e-03	150	136	5	IPR013026
Domain	SPRY	CMYA5 ASH2L RYR2 RYR3	4.95e-03	94	136	4	PF00622
Domain	SPRY_dom	CMYA5 ASH2L RYR2 RYR3	4.95e-03	94	136	4	IPR003877
Domain	B30.2/SPRY	CMYA5 ASH2L RYR2 RYR3	5.14e-03	95	136	4	IPR001870
Domain	B302_SPRY	CMYA5 ASH2L RYR2 RYR3	5.14e-03	95	136	4	PS50188
Domain	ConA-like_dom	CANX NBEA CMYA5 ASH2L RYR2 RYR3	5.40e-03	219	136	6	IPR013320
Domain	CBS	IMPDH1 IMPDH2	5.91e-03	16	136	2	SM00116
Domain	TPR-like_helical_dom	TANC2 DNAAF4 COPS2 CDC16 TANC1 LRP2BP	7.24e-03	233	136	6	IPR011990
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	TANC2 ATP6V1A SLC4A7 DSG1 MYCBP2 DSP BCLAF1 USP9X DOCK9 CANX CKAP5 PSD3 NBEA ZNFX1 SUCLA2 PGK1 RBM39 RYR2 PRUNE1 SHISA9 SERPINB5 UBXN4 CDC16 RTRAF SEC62 NAV1 CRYBG3	6.72e-14	1139	138	27	36417873
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	ATP6V1A TBRG4 IMPDH2 DSG1 DSP DYNC2H1 BCLAF1 USP9X CANX CKAP5 BAZ1B MYO1B CMYA5 SUCLA2 PGK1 RBM39 EIF2B1 RBM19 CDC16 RTRAF CPSF1 SGO2 PNPLA8 ATM HSD17B4 NIPBL TOP2B	1.22e-11	1425	138	27	30948266
Pubmed	Protein interactome mining defines melatonin MT1 receptors as integral component of presynaptic protein complexes of neurons.	EPS15 SLC4A7 IMPDH2 DSP DYNC2H1 CANX BAZ1B MYO1B SUCLA2 RBM39 ARHGAP1 CMIP CDC16 RTRAF	4.82e-11	322	138	14	26514267
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	CASP8AP2 MRPL20 EPS15 SLC4A7 PDPR ZNF148 IMPDH2 MYCBP2 DYNC2H1 BCLAF1 CANX NUCB1 PSD3 BAZ1B MRPL45 SUCLA2 ARHGAP1 NDUFAF4 UBXN4 MRPS33 PNPLA8 TANC1 ATM CRYBG3 MRPL9 TOP2B	1.77e-10	1487	138	26	33957083
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	MYCBP2 DSP USP9X CEP290 NUCB1 ASH1L CKAP5 NBEA ZNFX1 PSME1 CMYA5 PGK1 RYR3 SCYL2 ARHGAP1 MIA2 MORF4L1 RTRAF OSBPL1A ATM PJA1 HSD17B4 NIPBL AFF4	2.64e-10	1285	138	24	35914814
Pubmed	A High-Density Human Mitochondrial Proximity Interaction Network.	MRPL20 TBRG4 SLC4A7 PDPR MYCBP2 CANX MRPL45 SUCLA2 LARS2 RBM39 SCYL2 ARHGAP1 NDUFAF4 UBXN4 MIA2 MIGA2 MRPS33 NAV1 CPSF1 PNPLA8 TANC1 CRYBG3 HSD17B4 MRPL9	5.27e-09	1496	138	24	32877691
Pubmed	Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis.	ATP6V1A DNAH3 DSP BCLAF1 USP9X CANX DNAH2 TOPBP1 CKAP5 PSME1 PGK1 RBM39 PGK2 NDUFAF4 UBXN4 RTRAF MRPS33 NIPBL	7.97e-09	847	138	18	35235311
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	RAB12 EPS15 IMPDH2 DSP BCLAF1 USP9X CANX CD2AP SHB CKAP5 PSD3 MYO1B SCYL2 PRUNE1 ARHGAP1 CRYBG3	2.47e-08	708	138	16	39231216
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	ATP6V1A IMPDH2 DSG1 MYCBP2 DSP BCLAF1 USP9X CANX CEP290 CKAP5 BAZ1B MYO1B PGK1 RBM39 RTRAF CPSF1 HSD17B4 NIPBL TOP2B	2.59e-08	1024	138	19	24711643
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	TICRR DNAH3 CDKL2 DSP CANX TTI2 CEP290 MYOM3 OBSCN DNAH2 CKAP5 NBEA DNAH14 NDUFAF4 CPSF1 ATM	4.21e-08	736	138	16	29676528
Pubmed	Prediction of the coding sequences of unidentified human genes. XVI. The complete sequences of 150 new cDNA clones from brain which code for large proteins in vitro.	CASP8AP2 ASH1L ZNFX1 MAP10 SCYL2 STOX2 FGD6 LRP2BP	1.91e-07	153	138	8	10718198
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	ATP6V1A EPS15 ZNF148 IMPDH2 DSG1 DSP BCLAF1 CKAP5 BAZ1B MYO1B PGK1 RBM39 SCYL2 PRUNE1 NIPBL TOP2B AFF4	1.96e-07	934	138	17	33916271
Pubmed	Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.	ATP6V1A TBRG4 SLC4A7 IMPDH2 DSG1 DSP USP9X CANX CKAP5 PSME1 PGK1 RBM39 MIA2 RBM19 MORF4L1 RTRAF MRPS33 NAV1 HSD17B4 NIPBL TOP2B	1.96e-07	1415	138	21	28515276
Pubmed	Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells.	EPS15 PDPR IMPDH2 DSG1 DSP BCLAF1 USP9X CANX CD2AP CKAP5 PSME1 SUCLA2 COPS2 PGK1 RBM39 ARHGAP1 SERPINB5 UBXN4 RBM19 HSD17B4	4.96e-07	1367	138	20	32687490
Pubmed	A Map of Human Mitochondrial Protein Interactions Linked to Neurodegeneration Reveals New Mechanisms of Redox Homeostasis and NF-κB Signaling.	ATP6V1A IMPDH2 DSG1 DSP BCLAF1 CANX MYO1B PIP5K1C PGK1 SCYL2 ATG3 EIF2B1 RTRAF HSD17B4 TOP2B	5.97e-07	786	138	15	29128334
Pubmed	The HIV-1 Tat protein recruits a ubiquitin ligase to reorganize the 7SK snRNP for transcriptional activation.	RAB12 MRPL20 DSG1 DSP USP9X DOCK9 CANX MRPL45 CDK14 PIP5K1C PGK1 RBM39 ZNF503 EIF2B1 RTRAF OSBPL1A MRPS33 MRPL9	7.78e-07	1153	138	18	29845934
Pubmed	Systems analysis of RhoGEF and RhoGAP regulatory proteins reveals spatially organized RAC1 signalling from integrin adhesions.	TANC2 EPS15 IMPDH2 DSG1 DOCK9 CD2AP NBEA PIP5K1C ASH2L PGK1 RBM39 ARHGAP1 RTRAF CPSF1 HSD17B4 FGD6	7.89e-07	916	138	16	32203420
Pubmed	A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.	ATP6V1A TBRG4 IMPDH2 BCLAF1 CANX TTI2 MYO1B MRPL45 PSME1 SUCLA2 COPS2 RBM39 NDUFAF4 EIF2B1 RTRAF SEC62 MRPS33 ATM MRPL9 TOP2B	1.11e-06	1440	138	20	30833792
Pubmed	PRP19 transforms into a sensor of RPA-ssDNA after DNA damage and drives ATR activation via a ubiquitin-mediated circuitry.	IMPDH2 DSP CANX CKAP5 MYO1B RBM39 RTRAF CPSF1 NIPBL TOP2B	1.14e-06	340	138	10	24332808
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	MRPL20 IMPDH2 MYCBP2 DSP BCLAF1 CANX MYO1B MRPL45 UPF3A RBM39 MORF4L1 CPSF1 ATM HSD17B4 NIPBL TOP2B AFF4	1.48e-06	1082	138	17	38697112
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	TANC2 EPS15 IMPDH2 MYCBP2 BCLAF1 USP9X CANX CKAP5 NBEA ZNFX1 PGK1 STOX2 MORF4L1 NAV1 NIPBL AFF4	1.51e-06	963	138	16	28671696
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	ATP6V1A EPS15 MYCBP2 CD2AP WASF3 SHB ASH1L OBSCN CDK14 SUCLA2 RBM39 DNAH14 SHISA9 CMIP ASMTL NAV1 FOLH1B TANC1 CFAP69 AFF4	1.85e-06	1489	138	20	28611215
Pubmed	Phosphoproteome analysis of the human mitotic spindle.	DSP BCLAF1 CANX BAZ1B CDC16 SGO2 NIPBL TOP2B	2.10e-06	210	138	8	16565220
Pubmed	A CRISPR-based screen for Hedgehog signaling provides insights into ciliary function and ciliopathies.	EPS15 DSG1 DSP BCLAF1 SHB ARMC9 RYR3 C5 HSD17B4	2.17e-06	284	138	9	29459677
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	IMPDH2 MYCBP2 DSP USP9X CANX CKAP5 BAZ1B MYO1B PGK1 RBM39 CPSF1 ATM NIPBL	2.21e-06	653	138	13	22586326
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	CASP8AP2 ATP6V1A IMPDH2 BCLAF1 BAZ1B PSME1 COPS2 PGK1 SERPINB5 ATG3 EIF2B1 CDC16 CPSF1 ATM NIPBL TOP2B	2.93e-06	1014	138	16	32416067
Pubmed	Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.	TANC2 DSG1 DSP USP9X PSD3 PIP5K1C PGK1 RBM39 RTRAF HSD17B4 TOP2B	3.33e-06	475	138	11	31040226
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	EPS15 ASXL1 BCLAF1 CANX CD2AP TOPBP1 CKAP5 COPS2 PGK1 RBM39 STOX2 SERPINB5 CDC16 SGO2 ATM NIPBL TOP2B	3.55e-06	1155	138	17	20360068
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	PDPR MYCBP2 DSP USP9X CANX CEP290 PSD3 MYO1B NBEA PSME1 ARHGAP1 UBXN4 CPSF1 TANC1 CRYBG3 HSD17B4	4.49e-06	1049	138	16	27880917
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	ZNF789 DSP BCLAF1 NUCB1 SHB ASH1L DNAH2 MYO1B PGK1 PGK2 RYR2 UBXN4 MIA2 SEC62 ATM HSD17B4 CFAP69 NIPBL TOP2B	4.52e-06	1442	138	19	35575683
Pubmed	Nucleolar proteome dynamics.	TOPBP1 BAZ1B RBM39 RBM19 MORF4L1 RTRAF ATM HSD17B4 NIPBL TOP2B	7.27e-06	419	138	10	15635413
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	TANC2 IMPDH1 MYCBP2 DOCK9 MYOM3 OBSCN FHIP1B LARS2 PIP5K1C ZNF503 PIM3 RBM19 NAV1 CPSF1 ULK4 TANC1	8.61e-06	1105	138	16	35748872
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	TANC2 TBRG4 DYNC2H1 USP9X DNAH2 NBEA ZNFX1 ASH2L RYR2 SERPINB5 C5 NIPBL	9.77e-06	638	138	12	31182584
Pubmed	Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.	RAB12 TANC2 ATP6V1A MYCBP2 DOCK9 CANX NBEA SUCLA2 PGK1	1.10e-05	347	138	9	17114649
Pubmed	Proteomic characterization of chromosomal common fragile site (CFS)-associated proteins uncovers ATRX as a regulator of CFS stability.	DSG1 DSP BCLAF1 CANX TOPBP1 BAZ1B PGK1 SERPINB5 CPSF1 SGO2 NIPBL TOP2B	1.21e-05	652	138	12	31180492
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	ZNF148 MYCBP2 DSP BCLAF1 USP9X CD2AP BAZ1B ASH2L SCYL2 PRUNE1 CDC16	1.30e-05	549	138	11	38280479
Pubmed	Tumor suppressor BAP1 nuclear import is governed by transportin-1.	ATP6V1A EPS15 IMPDH2 MYCBP2 DSP USP9X CANX CD2AP CKAP5 MYO1B PSME1 COPS2 ASH2L PGK1 RBM39 RTRAF	1.39e-05	1149	138	16	35446349
Pubmed	Systematic proteomics of endogenous human cohesin reveals an interaction with diverse splicing factors and RNA-binding proteins required for mitotic progression.	DSP BCLAF1 CKAP5 PSD3 MYO1B RBM39 NIPBL TOP2B	1.39e-05	272	138	8	31010829
Pubmed	Large-scale mapping of human protein-protein interactions by mass spectrometry.	TBRG4 SLC4A7 IMPDH2 DSG1 MYCBP2 DSP BCLAF1 USP9X MYO1B CMYA5 CDK14 COPS2 ATG3 EIF2B1 MORF4L1 PITPNA SGO2	1.41e-05	1284	138	17	17353931
Pubmed	Expression of IMPDH mRNA after mycophenolate administration in male volunteers.	IMPDH1 IMPDH2	1.56e-05	2	138	2	25105143
Pubmed	Pharmacogenetics of the mycophenolic acid targets inosine monophosphate dehydrogenases IMPDH1 and IMPDH2: gene sequence variation and functional genomics.	IMPDH1 IMPDH2	1.56e-05	2	138	2	20718729
Pubmed	Structural Basis of MRG15-Mediated Activation of the ASH1L Histone Methyltransferase by Releasing an Autoinhibitory Loop.	ASH1L MORF4L1	1.56e-05	2	138	2	30827841
Pubmed	Structural Insights into Stimulation of Ash1L's H3K36 Methyltransferase Activity through Mrg15 Binding.	ASH1L MORF4L1	1.56e-05	2	138	2	30827843
Pubmed	Two distinct cDNAs for human IMP dehydrogenase.	IMPDH1 IMPDH2	1.56e-05	2	138	2	1969416
Pubmed	A factor stimulating transcription of the testis-specific Pgk-2 gene recognizes a sequence similar to the binding site for a transcription inhibitor of the somatic-type Pgk-1 gene.	PGK1 PGK2	1.56e-05	2	138	2	8441629
Pubmed	Tissue-specific alternative splicing of mouse brain type ryanodine receptor/calcium release channel mRNA.	RYR2 RYR3	1.56e-05	2	138	2	8898078
Pubmed	The family of mouse phosphoglycerate kinase genes and pseudogenes.	PGK1 PGK2	1.56e-05	2	138	2	2829366
Pubmed	The mouse sino-atrial node expresses both the type 2 and type 3 Ca(2+) release channels/ryanodine receptors.	RYR2 RYR3	1.56e-05	2	138	2	14550562
Pubmed	Characterization of phosphoglycerate kinase from human spermatozoa.	PGK1 PGK2	1.56e-05	2	138	2	1278465
Pubmed	Targeted disruption of the inosine 5'-monophosphate dehydrogenase type I gene in mice.	IMPDH1 IMPDH2	1.56e-05	2	138	2	12944494
Pubmed	MRG15 activates histone methyltransferase activity of ASH1L by recruiting it to the nucleosomes.	ASH1L MORF4L1	1.56e-05	2	138	2	37527654
Pubmed	Cloning and sequence analysis of the human and Chinese hamster inosine-5'-monophosphate dehydrogenase cDNAs.	IMPDH1 IMPDH2	1.56e-05	2	138	2	2902093
Pubmed	Characterization of human type I and type II IMP dehydrogenases.	IMPDH1 IMPDH2	1.56e-05	2	138	2	7903306
Pubmed	Recombinant human inosine monophosphate dehydrogenase type I and type II proteins. Purification and characterization of inhibitor binding.	IMPDH1 IMPDH2	1.56e-05	2	138	2	7763314
Pubmed	A DNA-topoisomerase-II-binding protein with eight repeating regions similar to DNA-repair enzymes and to a cell-cycle regulator.	TOPBP1 TOP2B	1.56e-05	2	138	2	9461304
Pubmed	Analysis of the cDNA and encoded protein of the human testis-specific PGK-2 gene.	PGK1 PGK2	1.56e-05	2	138	2	9023984
Pubmed	Phosphorylation-Dependent Regulation of the DNA Damage Response of Adaptor Protein KIBRA in Cancer Cells.	ATM WWC1	1.56e-05	2	138	2	26929199
Pubmed	Inosine 5'-monophosphate dehydrogenase binds nucleic acids in vitro and in vivo.	IMPDH1 IMPDH2	1.56e-05	2	138	2	14766016
Pubmed	Altered ryanodine receptor expression in mild cognitive impairment and Alzheimer's disease.	RYR2 RYR3	1.56e-05	2	138	2	21531043
Pubmed	Modulation of calcium signalling by dominant negative splice variant of ryanodine receptor subtype 3 in native smooth muscle cells.	RYR2 RYR3	1.56e-05	2	138	2	16678258
Pubmed	Regulation of DNA replication through Sld3-Dpb11 interaction is conserved from yeast to humans.	TICRR TOPBP1	1.56e-05	2	138	2	21700459
Pubmed	Human testis-specific PGK gene lacks introns and possesses characteristics of a processed gene.	PGK1 PGK2	1.56e-05	2	138	2	3453121
Pubmed	Characterization of the human inosine-5'-monophosphate dehydrogenase type II gene.	IMPDH1 IMPDH2	1.56e-05	2	138	2	7896827
Pubmed	C5a regulates IL-12+ DC migration to induce pathogenic Th1 and Th17 cells in sepsis.	IL12A C5	1.56e-05	2	138	2	23936099
Pubmed	Transcription switch of two phosphoglycerate kinase genes during spermatogenesis as determined with mouse testis sections in situ.	PGK1 PGK2	1.56e-05	2	138	2	2298243
Pubmed	Polymorphisms in type I and II inosine monophosphate dehydrogenase genes and association with clinical outcome in patients on mycophenolate mofetil.	IMPDH1 IMPDH2	1.56e-05	2	138	2	20679962
Pubmed	Expression of inosine monophosphate dehydrogenase type I and type II after mycophenolate mofetil treatment: a 2-year follow-up in kidney transplantation.	IMPDH1 IMPDH2	1.56e-05	2	138	2	17713475
Pubmed	Selective activation of testis-specific genes in cultured rat spermatogenic cells.	PGK1 PGK2	1.56e-05	2	138	2	2166582
Pubmed	Mutants of purine metabolism in cultured mouse and hamster cells.	IMPDH1 IMPDH2	1.56e-05	2	138	2	988789
Pubmed	Human phosphoglycerate kinase. I. Crystallization and characterization of normal enzyme.	PGK1 PGK2	1.56e-05	2	138	2	5009693
Pubmed	N6-methyladenosine-modified circCDK14 promotes ossification of the ligamentum flavum via epigenetic modulation by targeting AFF4.	CDK14 AFF4	1.56e-05	2	138	2	39414635
Pubmed	Differential appearance of DNase I-hypersensitive sites correlates with differential transcription of Pgk genes during spermatogenesis in the mouse.	PGK1 PGK2	1.56e-05	2	138	2	8662942
Pubmed	A vertebrate gene, ticrr, is an essential checkpoint and replication regulator.	TICRR TOPBP1	1.56e-05	2	138	2	20080954
Pubmed	Exome sequencing reveals pathogenic mutations in the LARS2 and HSD17B4 genes associated with Perrault syndrome and D-bifunctional protein deficiency in Moroccan families.	LARS2 HSD17B4	1.56e-05	2	138	2	39052101
Pubmed	Decreased expression of ryanodine receptors alters calcium-induced calcium release mechanism in mdx duodenal myocytes.	RYR2 RYR3	1.56e-05	2	138	2	14985349
Pubmed	Regulation of dendritic spines, spatial memory, and embryonic development by the TANC family of PSD-95-interacting proteins.	TANC2 TANC1	1.56e-05	2	138	2	21068316
Pubmed	Transcription factor Foxp3 and its protein partners form a complex regulatory network.	ZNF148 BCLAF1 CD2AP TOPBP1 CKAP5 ASH2L RBM19 ATM FYB1	1.82e-05	370	138	9	22922362
Pubmed	Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors.	RAB12 TBRG4 SLC4A7 PDPR DSP USP9X CANX NUCB1 OAS1 SUCLA2 ASH2L RBM39 UBXN4 RTRAF SEC62 CPSF1 HSD17B4 MRPL9	1.85e-05	1451	138	18	30550785
Pubmed	Identification of dynein heavy chain genes expressed in human and mouse testis: chromosomal localization of an axonemal dynein gene.	DNAH3 DYNC2H1 DNAH2	2.15e-05	14	138	3	9373155
Pubmed	The protein interaction landscape of the human CMGC kinase group.	ASXL1 IMPDH2 DSG1 CDKL2 BCLAF1 USP9X CDK14 RBM39 SERPINB10 NAV1 CPSF1 AFF4	2.27e-05	695	138	12	23602568
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	CASP8AP2 DSP DYNC2H1 USP9X CANX TOPBP1 BAZ1B MYO1B NAV1 TANC1 CRYBG3	2.44e-05	588	138	11	38580884
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	EPS15 SLC4A7 IMPDH1 IMPDH2 CD2AP TOPBP1 CKAP5 BAZ1B ASH2L UBXN4 RBM19 CDC16 MORF4L1 RTRAF TANC1 NIPBL MRPL9 AFF4	2.79e-05	1497	138	18	31527615
Pubmed	EDEM1 Drives Misfolded Protein Degradation via ERAD and Exploits ER-Phagy as Back-Up Mechanism When ERAD Is Impaired.	RAB12 CANX UBXN4 ATG3 SEC62 ATM	3.13e-05	150	138	6	32423001
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	USP9X DOCK9 OBSCN NBEA COPS2 RBM39 RYR3 NDUFAF4 CPSF1 ATM	3.14e-05	497	138	10	36774506
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	ATP6V1A IMPDH1 DSG1 DSP BCLAF1 MYO1B SUCLA2 PGK1 EIF2B1 RBM19 CDC16 RTRAF SEC62 MRPS33 CPSF1 C5 AFF4	3.24e-05	1371	138	17	36244648
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	ZNF148 IMPDH2 MYCBP2 BCLAF1 NAB1 CKAP5 PSME1 PGK1 RBM39 ZNF503 MORF4L1 RTRAF HSD17B4 NIPBL TOP2B	3.45e-05	1103	138	15	34189442
Pubmed	A comprehensive SARS-CoV-2-human protein-protein interactome reveals COVID-19 pathobiology and potential host therapeutic targets.	IMPDH1 IMPDH2 BCLAF1 CANX MYO1B PGK1 PGK2 ZNF503 EIF2B1 MORF4L1	3.48e-05	503	138	10	36217030
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	ATP6V1A DSP CD2AP CEP290 SHB CKAP5 UBAP1 PSME1 FHIP1B RBM39 ARHGAP1 TANC1 HSD17B4	3.75e-05	853	138	13	28718761
Pubmed	Comparative interactome analysis of α-arrestin families in human and Drosophila.	ATP6V1A BCLAF1 USP9X MYO1B ASH2L CPSF1 ATM PJA1	3.79e-05	313	138	8	38270169
Pubmed	Genetic Screens Reveal FEN1 and APEX2 as BRCA2 Synthetic Lethal Targets.	TTI2 TOPBP1 UBXN4 SGO2 ATM NIPBL	4.04e-05	157	138	6	30686591
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	IMPDH2 DSG1 DSP BCLAF1 CANX CKAP5 BAZ1B MYO1B PGK1 RBM39 ARHGAP1 RBM19 CDC16 RTRAF NAV1 CPSF1	4.12e-05	1257	138	16	36526897
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	TANC2 SLC4A7 MYCBP2 DSP CD2AP CKAP5 PSD3 CDK14 STOX2 NAV1 TANC1 CRYBG3 FGD6	4.12e-05	861	138	13	36931259
Pubmed	TNRC6 proteins modulate hepatitis C virus replication by spatially regulating the binding of miR-122/Ago2 complexes to viral RNA.	DSG1 DSP DNAH2 CKAP5 MYO1B RBM39 MORF4L1 TOP2B	4.15e-05	317	138	8	30997501
Pubmed	Interactome of vertebrate GAF/ThPOK reveals its diverse functions in gene regulation and DNA repair.	CASP8AP2 ZNF148 IMPDH2 DSG1 MYO1B FHIP1B RTRAF TOP2B	4.53e-05	321	138	8	32098917
Pubmed	Type 1 and type 3 ryanodine receptors are selectively involved in muscarinic antinociception in mice: an antisense study.	RYR2 RYR3	4.68e-05	3	138	2	18403125
Pubmed	Serological Epithelial Component Proteins Identify Intestinal Complications in Crohn's Disease.	DSG1 DSP	4.68e-05	3	138	2	28490445
Pubmed	Control of Neuronal Ryanodine Receptor-Mediated Calcium Signaling by Calsenilin.	RYR2 RYR3	4.68e-05	3	138	2	29730765
Pubmed	CMYA5 establishes cardiac dyad architecture and positioning.	CMYA5 RYR2	4.68e-05	3	138	2	35449169
Pubmed	Tanc1/2 TPR domain interacts with Myo18a C-terminus and undergoes liquid-liquid phase separation.	TANC2 TANC1	4.68e-05	3	138	2	38092135
Pubmed	Uncoupling of hypomyelination and glial cell death by a mutation in the proteolipid protein gene.	PGK1 PGK2	4.68e-05	3	138	2	1380672
Interaction	MCUB interactions	MRPL20 MRPL45 SUCLA2 LARS2 NDUFAF4 SEC62 MRPS33 PNPLA8 MRPL9	2.74e-06	172	137	9	int:MCUB
Interaction	H2BC21 interactions	TICRR DSG1 BCLAF1 OBSCN DNAH2 BAZ1B CDK14 ASH2L ATG3 CDC16 MORF4L1 SGO2 SAGE1 FYB1 NIPBL TOP2B LRP2BP	5.15e-06	696	137	17	int:H2BC21
Interaction	HINT2 interactions	MRPL20 TBRG4 PDPR SH2D3C MRPL45 SUCLA2 LARS2 NDUFAF4 MRPS33 PNPLA8 MRPL9	2.32e-05	343	137	11	int:HINT2
Interaction	DLST interactions	TBRG4 IMPDH1 IMPDH2 DSP CANX CKAP5 MYO1B SUCLA2 ASH2L PGK1 RBM39 HSD17B4 TOP2B	3.05e-05	490	137	13	int:DLST
Interaction	CS interactions	MRPL20 TBRG4 PDPR SH2D3C MRPL45 SUCLA2 LARS2 ANKRD55 RBM39 NDUFAF4 MRPS33 PNPLA8 MRPL9	3.05e-05	490	137	13	int:CS
Interaction	BIRC3 interactions	ATP6V1A IMPDH2 DSG1 DSP DYNC2H1 BCLAF1 USP9X CANX CKAP5 BAZ1B MYO1B CMYA5 SUCLA2 PGK1 RBM39 EIF2B1 RBM19 RTRAF CPSF1 SGO2 PNPLA8 HSD17B4 TOP2B	3.24e-05	1334	137	23	int:BIRC3
Interaction	ARRDC2 interactions	IMPDH1 USP9X ASH2L CPSF1 PJA1	3.27e-05	54	137	5	int:ARRDC2
Interaction	FASTKD5 interactions	MRPL20 ASXL1 TBRG4 PDPR MRPL45 SUCLA2 LARS2 NDUFAF4 MRPS33 MRPL9	4.22e-05	302	137	10	int:FASTKD5
Interaction	COQ2 interactions	DSG1 DSP BCLAF1 PIP5K1C PGK1 SCYL2	4.41e-05	94	137	6	int:COQ2
Interaction	TUFM interactions	ATP6V1A MRPL20 ASXL1 PDPR DSP CANX MRPL45 SUCLA2 LARS2 ANKRD55 RBM39 NDUFAF4 MRPS33 PNPLA8 MRPL9	6.81e-05	686	137	15	int:TUFM
Interaction	GAPDH interactions	ASXL1 DSP CEP290 NUCB1 OBSCN ANKRD55 PGK1 RBM39 ATG3 SEC62 OSMR HSD17B4 NIPBL TOP2B AFF4	6.81e-05	686	137	15	int:GAPDH
Interaction	COX8A interactions	MRPL20 TBRG4 SLC4A7 PDPR CANX MRPL45 SUCLA2 LARS2 NDUFAF4 PNPLA8	7.22e-05	322	137	10	int:COX8A
Interaction	GATD3 interactions	MRPL20 TBRG4 PDPR MRPL45 SUCLA2 LARS2 NDUFAF4 MRPS33 PNPLA8 PJA1 MRPL9	9.09e-05	399	137	11	int:GATD3
Interaction	LONP1 interactions	ATP6V1A MRPL20 TBRG4 CANX MRPL45 UPF3A SUCLA2 LARS2 ARHGAP1 NDUFAF4 MRPS33 PNPLA8	1.07e-04	479	137	12	int:LONP1
Interaction	METTL15 interactions	MRPL20 TBRG4 PDPR MYCBP2 MRPL45 SUCLA2 NDUFAF4 MRPS33 MRPL9	1.10e-04	274	137	9	int:METTL15
Interaction	EED interactions	MRPL20 ASXL1 IMPDH2 MYCBP2 DSP BCLAF1 USP9X CEP290 OBSCN CKAP5 BAZ1B MYO1B PGK1 RBM39 PRUNE1 ARHGAP1 CPNE6 RBM19 CPSF1 TANC1 PJA1 HSD17B4 NIPBL	1.10e-04	1445	137	23	int:EED
Interaction	FASTKD2 interactions	ATP6V1A MRPL20 TBRG4 PDPR SH2D3C MRPL45 NDUFAF4 MRPS33 MRPL9	1.16e-04	276	137	9	int:FASTKD2
Interaction	CDKL2 interactions	CDKL2 DSP BCLAF1 MYO1B CDK14	1.23e-04	71	137	5	int:CDKL2
Interaction	MTIF2 interactions	MRPL20 TBRG4 PDPR MRPL45 SUCLA2 LARS2 NDUFAF4 MRPS33 PNPLA8 MRPL9	1.27e-04	345	137	10	int:MTIF2
Interaction	MTNR1A interactions	EPS15 CANX BAZ1B SUCLA2 RBM39 CMIP RTRAF	1.42e-04	166	137	7	int:MTNR1A
Interaction	TRUB2 interactions	MRPL20 TBRG4 PDPR MRPL45 SUCLA2 LARS2 NDUFAF4 MRPS33 PNPLA8 MRPL9	1.43e-04	350	137	10	int:TRUB2
Interaction	ACAD9 interactions	MRPL20 TBRG4 PDPR MRPL45 SUCLA2 LARS2 SERPINB5 NDUFAF4 MRPS33 PNPLA8 MRPL9	1.46e-04	421	137	11	int:ACAD9
Interaction	CCDC90B interactions	MRPL20 PDPR MRPL45 SUCLA2 LARS2 NDUFAF4 MRPS33 PNPLA8	1.46e-04	223	137	8	int:CCDC90B
Interaction	KPNA1 interactions	ZNF148 MYCBP2 USP9X BAZ1B COPS2 ASH2L SERPINB5 MORF4L1 ATM NIPBL	1.46e-04	351	137	10	int:KPNA1
Interaction	CDK15 interactions	DSP PSME1 CDK14 ARHGAP1 SERPINB5 AFF4	1.49e-04	117	137	6	int:CDK15
Interaction	RNF123 interactions	TICRR DNAH3 CDKL2 DSP CANX TTI2 CEP290 MYOM3 OBSCN DNAH2 CKAP5 NBEA DNAH14 NDUFAF4 CPSF1 ATM	1.54e-04	824	137	16	int:RNF123
Interaction	TMEM70 interactions	MRPL20 IMPDH1 MRPL45 SUCLA2 NDUFAF4 MRPS33 PNPLA8 MRPL9	1.55e-04	225	137	8	int:TMEM70
Interaction	MTERF3 interactions	MRPL20 TBRG4 PDPR MRPL45 SUCLA2 LARS2 NDUFAF4 SEC62 MRPS33 MRPL9	1.57e-04	354	137	10	int:MTERF3
Interaction	MTRES1 interactions	MRPL20 PDPR MRPL45 SUCLA2 LARS2 NDUFAF4 MRPS33 PNPLA8 MRPL9	1.64e-04	289	137	9	int:MTRES1
Interaction	SSBP1 interactions	MRPL20 TBRG4 PDPR CEP290 MRPL45 SUCLA2 LARS2 PGK1 NDUFAF4 MRPS33 PNPLA8 HSD17B4 MRPL9	1.91e-04	588	137	13	int:SSBP1
Interaction	HSPD1 interactions	ATP6V1A MRPL20 ASXL1 TBRG4 PDPR DNAH2 BAZ1B MRPL45 UPF3A SUCLA2 LARS2 ANKRD55 RBM39 RYR3 NDUFAF4 MRPS33 HSD17B4 MRPL9	1.97e-04	1022	137	18	int:HSPD1
Interaction	TSFM interactions	MRPL20 TBRG4 PDPR MRPL45 SUCLA2 LARS2 NDUFAF4 MRPS33 PNPLA8 MRPL9	2.19e-04	369	137	10	int:TSFM
Interaction	PMPCB interactions	MRPL20 PDPR CEP290 MRPL45 SUCLA2 LARS2 NDUFAF4 MRPS33 PNPLA8 MRPL9	2.29e-04	371	137	10	int:PMPCB
Interaction	HNRNPU interactions	ASXL1 BCLAF1 CEP290 CKAP5 BAZ1B MRPL45 PSME1 MAP10 RBM39 ATG3 EIF2B1 MORF4L1 RTRAF SEC62 MRPS33 HSD17B4 FGD6 MRPL9	2.30e-04	1035	137	18	int:HNRNPU
Interaction	MRPS26 interactions	MRPL20 TBRG4 PDPR MRPL45 SUCLA2 LARS2 RBM39 NDUFAF4 MRPS33 PNPLA8 MRPL9	2.49e-04	448	137	11	int:MRPS26
Interaction	MTRF1 interactions	MRPL20 PDPR MRPL45 SUCLA2 LARS2 NDUFAF4 MRPS33 MRPL9	2.62e-04	243	137	8	int:MTRF1
Interaction	MTRF1L interactions	MRPL20 PDPR MRPL45 SUCLA2 LARS2 NDUFAF4 MRPS33 MRPL9	2.62e-04	243	137	8	int:MTRF1L
Interaction	SFN interactions	TANC2 SLC4A7 IMPDH2 MYCBP2 CD2AP PGK1 RBM39 PIM3 STOX2 SERPINB5 NAV1 TANC1 CRYBG3 FGD6	2.68e-04	692	137	14	int:SFN
Interaction	SURF1 interactions	MRPL20 PDPR OBSCN MRPL45 LARS2 NDUFAF4 PNPLA8	2.86e-04	186	137	7	int:SURF1
Interaction	KCNA3 interactions	RAB12 EPS15 IMPDH2 DSP BCLAF1 USP9X CANX CD2AP SHB CKAP5 PSD3 MYO1B SCYL2 PRUNE1 ARHGAP1 CRYBG3	2.87e-04	871	137	16	int:KCNA3
Interaction	YWHAG interactions	TANC2 ATP6V1A TICRR SLC4A7 MYCBP2 DSP BCLAF1 DOCK9 CD2AP SH2D3C SHB CKAP5 PSD3 CDK14 ANKRD55 STOX2 NAV1 TANC1 FGD6 WWC1	2.97e-04	1248	137	20	int:YWHAG
Interaction	BRCA2 interactions	ASXL1 TTI2 TOPBP1 ASH2L ZNF503 UBXN4 MORF4L1 SGO2 ATM NIPBL	3.01e-04	384	137	10	int:BRCA2
Interaction	PMPCA interactions	MRPL20 PDPR MRPL45 SUCLA2 LARS2 COPS2 NDUFAF4 MRPS33 PNPLA8 MRPL9	3.01e-04	384	137	10	int:PMPCA
Interaction	GFM2 interactions	MRPL20 PDPR MRPL45 LARS2 NDUFAF4 MRPS33 MRPL9	3.05e-04	188	137	7	int:GFM2
Interaction	RPL10 interactions	MRPL20 IMPDH2 BAZ1B ANKRD55 RBM39 EIF2B1 MORF4L1 RTRAF MRPS33 OGFOD1 NIPBL MRPL9 GGPS1 TOP2B	3.10e-04	702	137	14	int:RPL10
GeneFamily	Ryanodine receptors\|Protein phosphatase 1 regulatory subunits	RYR2 RYR3	7.49e-05	3	91	2	287
GeneFamily	Dyneins, axonemal	DNAH3 DNAH2 DNAH14	7.97e-05	17	91	3	536
GeneFamily	Zinc fingers MYND-type\|A-kinase anchoring proteins	AKAP3 NBEA CMYA5	4.10e-04	29	91	3	396
GeneFamily	Mitochondrial ribosomal proteins	MRPL20 MRPL45 MRPS33 MRPL9	6.76e-04	79	91	4	646
GeneFamily	Tetratricopeptide repeat domain containing\|Bardet-Biedl syndrome associated\|BBSome	TANC2 DNAAF4 CDC16 TANC1	2.71e-03	115	91	4	769
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	EPS15 ASXL1 SLC4A7 ZNF148 MYCBP2 USP9X DOCK9 CD2AP WASF3 SHB TOPBP1 CKAP5 PSD3 BAZ1B MYO1B LARS2 RBM39 MIA2 CDC16 CRYBG3 OSMR NIPBL WWC1	1.12e-10	856	137	23	M4500
Coexpression	HAMAI_APOPTOSIS_VIA_TRAIL_UP	CASP8AP2 ZNF148 MYCBP2 BCLAF1 USP9X CEP290 BAZ1B UPF3A TRAPPC13 STOX2 ABCA5 SEC62 OSBPL1A ATM FYB1 NIPBL TOP2B	6.26e-08	656	137	17	M18979
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	EPS15 SLC4A7 ZNF148 MYCBP2 USP9X CD2AP WASF3 SHB TOPBP1 CKAP5 MYO1B LARS2 RBM39 WWC1	1.68e-07	466	137	14	M13522
Coexpression	MURARO_PANCREAS_BETA_CELL	RAB12 TANC2 ATP6V1A SLC4A7 MYCBP2 DSP USP9X CANX ASH1L PSD3 NBEA COPS2 PGK1 PIM3 UBXN4 ABCA5 ATG3 AFF4	2.27e-06	946	137	18	M39169
Coexpression	NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP	ATP6V1A EPS15 SLC4A7 ZNF148 USP9X CEP290 TOPBP1 UBAP1 OAS1 UPF3A COPS2 RYR3 SCYL2 ASMTL EIF2B1 CDC16 SEC62 PITPNA ATM NIPBL	5.32e-06	1215	137	20	M41122
Coexpression	GSE17721_PAM3CSK4_VS_CPG_16H_BMDC_DN	SH2D3C ZNFX1 GRK1 TRAPPC13 MIGA2 MORF4L1 SLC28A2 C5	1.04e-05	199	137	8	M3870
Coexpression	GSE25123_CTRL_VS_ROSIGLITAZONE_STIM_MACROPHAGE_DN	MRPL20 PGK1 C5orf47 RYR3 MORF4L1 RTRAF MRPS33 NIPBL	1.08e-05	200	137	8	M7907
Coexpression	DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_UP	CASP8AP2 ATP6V1A EPS15 TBRG4 USP9X CANX CD2AP TOPBP1 UPF3A SUCLA2 COPS2 ASH2L PGK1 RBM39 ASMTL EIF2B1 CDC16 MORF4L1 PITPNA CPSF1 HSD17B4	1.24e-05	1399	137	21	M535
Coexpression	SCHLOSSER_SERUM_RESPONSE_DN	EPS15 DSG1 MYCBP2 BCLAF1 CANX CD2AP TOPBP1 PSD3 OAS1 SUCLA2 PGK1 ASMTL SEC62 TOP2B	2.05e-05	705	137	14	M1410
Coexpression	GSE25146_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_AGS_CELL_DN	MYCBP2 BCLAF1 DOCK9 ASH1L RBM39 NIPBL AFF4	2.78e-05	166	137	7	M8129
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	EPS15 THEMIS SLC4A7 ZNF148 MYCBP2 BCLAF1 USP9X DOCK9 SH2D3C ASH1L BAZ1B ZNFX1 PSME1 PGK1 RBM39 UBXN4 CDC16 ATM FYB1 NIPBL TOP2B	3.20e-05	1492	137	21	M40023
Coexpression	BASAKI_YBX1_TARGETS_DN	DYNC2H1 PSD3 PGK1 RBM39 UBXN4 ABCA5 ASMTL SEC62 NAV1 ATM	4.82e-05	398	137	10	M14877
Coexpression	GSE18893_TCONV_VS_TREG_2H_TNF_STIM_DN	TANC2 ZNF148 MYCBP2 PNPLA8 ATM PLEK AFF4	7.46e-05	194	137	7	M7306
Coexpression	GSE24081_CONTROLLER_VS_PROGRESSOR_HIV_SPECIFIC_CD8_TCELL_DN	CASP8AP2 DSP PSD3 OAS1 MYO1B ATG3 PLEK	8.22e-05	197	137	7	M4540
Coexpression	SHEN_SMARCA2_TARGETS_UP	BCLAF1 USP9X NAB1 UPF3A SUCLA2 COPS2 ATG3 MORF4L1 SEC62 OSBPL1A	8.98e-05	429	137	10	M29
Coexpression	GSE27786_CD8_TCELL_VS_ERYTHROBLAST_UP	CASP8AP2 BCLAF1 MRPL45 PIM3 NDUFAF4 OGFOD1 NIPBL	9.03e-05	200	137	7	M4841
Coexpression	GSE17721_CTRL_VS_POLYIC_12H_BMDC_UP	EPS15 MYCBP2 NUCB1 TOPBP1 BAZ1B MIGA2 CPSF1	9.03e-05	200	137	7	M3719
Coexpression	GSE27859_CD11C_INT_F480_HI_MACROPHAGE_VS_CD11C_ING_F480_INT_DC_DN	RBM39 ARHGAP1 SEC62 C5 NIPBL MRPL9 AFF4	9.03e-05	200	137	7	M8598
Coexpression	GSE46143_CTRL_VS_LMP2A_TRANSDUCED_CD10_POS_GC_BCELL_DN	RAB12 ASH1L TOPBP1 ASH2L ARHGAP1 PITPNA NAV1	9.03e-05	200	137	7	M9773
Coexpression	GSE17721_POLYIC_VS_CPG_24H_BMDC_DN	SLC4A7 TTI2 NUCB1 FHIP1B CDC16 HSD17B4 WWC1	9.03e-05	200	137	7	M3954
Coexpression	GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_IL4_TREATED_MACROPHAGE_DN	SLC4A7 MYCBP2 NAB1 RYR3 RTRAF MRPS33 NIPBL	9.03e-05	200	137	7	M7913
Coexpression	SESTO_RESPONSE_TO_UV_C5	EPS15 ZNF148 SHB CKAP5	9.83e-05	46	137	4	M1470
Coexpression	LAKE_ADULT_KIDNEY_C2_PODOCYTES	DYNC2H1 PSD3 MYO1B CMYA5 RYR3 TANC1 SPAG16	1.30e-04	212	137	7	M39221
Coexpression	BENPORATH_CYCLING_GENES	CASP8AP2 ASXL1 MYCBP2 DSP BCLAF1 NAB1 TOPBP1 CKAP5 ZNFX1 CDC16 SEC62 NIPBL	1.58e-04	648	137	12	M8156
Coexpression	GSE6092_CTRL_VS_BORRELIA_BIRGDOFERI_INF_ENDOTHELIAL_CELL_UP	IL12A CKAP5 BAZ1B ARHGAP1 MRPS33 OGFOD1	1.75e-04	156	137	6	M6707
Coexpression	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN	RAB12 BCLAF1 CANX CD2AP MYO1B CDK14 MIA2 MORF4L1 NAV1 WWC1	1.79e-04	467	137	10	M1347
Coexpression	GSE7596_AKT_TRANSD_VS_CTRL_CD4_TCONV_WITH_TGFB_UP	ATP6V1A BAZ1B SEC62 SLC28A2 PNPLA8 FYB1	2.00e-04	160	137	6	M339
Coexpression	DER_IFN_BETA_RESPONSE_UP	EPS15 BCLAF1 OAS1 PSME1 EIF2B1	2.11e-04	103	137	5	M13453
CoexpressionAtlas	DevelopingKidney_e15.5_stage III -IV renal corpusc_emap-27945_k-means-cluster#5_top-relative-expression-ranked_1000	MYCBP2 USP9X CANX CD2AP NAB1 BAZ1B LARS2 RBM39 UBXN4 WWC1	1.65e-06	226	133	10	gudmap_developingKidney_e15.5_stage III -IV renal corpusc_1000_k5
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3	CASP8AP2 SLC4A7 DYNC2H1 CANX CEP290 CKAP5 FGD6 NIPBL	2.89e-05	192	133	8	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_1000	TANC2 MYCBP2 USP9X CANX ASH1L BAZ1B RYR2 SCYL2 PJA1 TOP2B	4.47e-05	330	133	10	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_1000
CoexpressionAtlas	DevelopingKidney_e15.5_S-shaped body_emap-27855_k-means-cluster#5_top-relative-expression-ranked_1000	MYCBP2 USP9X CANX BAZ1B FHIP1B RBM39 WWC1	4.91e-05	152	133	7	gudmap_developingKidney_e15.5_S-shaped body_1000_k5
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5	ZDHHC2 CASP8AP2 DYNC2H1 USP9X CANX CEP290 ASH1L CKAP5 UBAP1 BAZ1B UPF3A SCYL2 CFAP69 NIPBL TOP2B AFF4	6.52e-05	831	133	16	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500	ZDHHC2 CASP8AP2 SLC4A7 DYNC2H1 CANX CEP290 CKAP5 LARS2 STOX2 FGD6 NIPBL WWC1	7.14e-05	498	133	12	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e15.5_Urothelium_emap-28091_k-means-cluster#1_top-relative-expression-ranked_1000	MYCBP2 USP9X CANX CD2AP BAZ1B NDUFAF4 TOP2B	1.11e-04	173	133	7	gudmap_developingLowerUrinaryTract_e15.5_Urothelium_1000_k1
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#4	CASP8AP2 SLC4A7 DYNC2H1 BCLAF1 CEP290 CKAP5 LARS2 STOX2 RBM19	1.11e-04	298	133	9	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K4
CoexpressionAtlas	DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#1_top-relative-expression-ranked_1000	ZDHHC2 NAB1 RYR3 NDUFAF4 ATG3 TOP2B	1.26e-04	123	133	6	gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000_k1
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000	ZDHHC2 CASP8AP2 SLC4A7 DYNC2H1 CANX CEP290 CKAP5 BAZ1B MRPL45 LARS2 ZNF503 STOX2 CFAP69 FGD6 NIPBL TOP2B WWC1	1.51e-04	989	133	17	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2	CASP8AP2 SLC4A7 CANX CEP290 CKAP5 BAZ1B FGD6 NIPBL TOP2B	1.54e-04	311	133	9	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2
CoexpressionAtlas	DevelopingKidney_e14.5 whole kidney - wildtype_emap-6674_k-means-cluster#3_top-relative-expression-ranked_1000	DSP BCLAF1 SCYL2 STOX2 ULK4 NIPBL	1.63e-04	129	133	6	gudmap_developingKidney_e14.5 whole kidney - wildtype_1000_k3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5	CASP8AP2 BCLAF1 CEP290 DNAH2 BAZ1B NAV1 SGO2	1.74e-04	186	133	7	Facebase_RNAseq_e10.5_Mandibular Arch_500_K5
CoexpressionAtlas	DevelopingLowerUrinaryTract_e15.5_Urothelium_emap-28091_top-relative-expression-ranked_500	MYCBP2 CDKL2 DSP USP9X CANX CD2AP BAZ1B SCYL2 SERPINB5 WWC1	1.92e-04	394	133	10	gudmap_developingLowerUrinaryTract_e15.5_urothelium_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#5_top-relative-expression-ranked_1000	TANC2 USP9X CANX ASH1L BAZ1B RBM39 RYR2 STOX2 PJA1 TOP2B	2.04e-04	397	133	10	gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000_k5
ToppCell	(11)_FOXN4+-(2)_GFP_FOXI1\|(11)_FOXN4+ / shred by cell type by condition	TANC2 MYCBP2 BCLAF1 CD2AP CEP290 MRPL45 RBM39 UBXN4 NIPBL	1.21e-08	198	138	9	76d40b8c2f8399725b3a62ee2ae0896559cf91eb
ToppCell	Calu_3-infected\|Calu_3 / Cell line, Condition and Strain	DSP USP9X CD2AP ASH1L OAS1 ZNFX1 FGD6 AFF4	1.09e-07	183	138	8	8f7f5000645f24f20a8d7700c4df1f8953a1780b
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZNF148 DSP CD2AP ASH1L MYO1B CMIP PITPNA TOP2B	1.51e-07	191	138	8	60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZNF148 DSP CD2AP ASH1L MYO1B CMIP PITPNA TOP2B	1.51e-07	191	138	8	09db184cb90fe282a14474d7217068c58092c6f8
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL-30m\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZNF148 DSP CD2AP ASH1L MYO1B CMIP PITPNA TOP2B	1.51e-07	191	138	8	973117730d6ba5f127e7a0bfabfd0ff2ca7ac131
ToppCell	IPF-Multiplet-Multiplet\|IPF / Disease state, Lineage and Cell class	DNAH3 DYNC2H1 NBEA TMEM232 TANC1 SPAG16 CFAP69 WWC1	1.77e-07	195	138	8	fce0c29574bb7aab181b9c00feb42681e285d1f2
ToppCell	IPF-Multiplet\|IPF / Disease state, Lineage and Cell class	DNAH3 DYNC2H1 NBEA TMEM232 TANC1 SPAG16 CFAP69 WWC1	1.77e-07	195	138	8	eacc0449ae6f3ad8002268cd061467684c6fb9a7
ToppCell	(09)_Interm._secr.>cil.-(2)_GFP_FOXI1\|(09)_Interm._secr.>cil. / shred by cell type by condition	TANC2 BCLAF1 CD2AP CEP290 MRPL45 UBXN4 OSBPL1A NIPBL	2.06e-07	199	138	8	fc680f85ebd3bab4c72876a19a461b0afb5f51ce
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	MYCBP2 BCLAF1 ASH1L OAS1 RBM39 ATM NIPBL AFF4	2.15e-07	200	138	8	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	droplet-Marrow-nan-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYCBP2 BCLAF1 CD2AP BAZ1B MIA2 NIPBL TOP2B	1.76e-06	184	138	7	1154a5ad7b8512272b7476f949ddac350910bfb7
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	EPHX2 DOCK9 OBSCN ANKRD55 TRAPPC13 ATM FYB1	1.76e-06	184	138	7	5350b58aa9979631228835d11eb45ddf81d08bff
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TANC2 SLC4A7 CDKL2 DNAH14 SHISA9 STOX2 WWC1	2.18e-06	190	138	7	3fc9e18c7441c0ae8cda65753cc42d0520f4e116
ToppCell	Adult-Epithelial\|Adult / Lineage, Cell type, age group and donor	DOCK9 MYO1B DNAH14 STOX2 TANC1 OSMR WWC1	2.34e-06	192	138	7	efb962a5fd3b9bdfd8cf8d13c435e29c8271713e
ToppCell	facs-Aorta-Heart-3m\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATP6V1A USP9X CD2AP LARS2 CMIP FGD6 TOP2B	2.34e-06	192	138	7	1ccc47792edf9ee23501c8e2165d11271636b66a
ToppCell	Control-Epithelial-Ciliated\|Epithelial / Disease state, Lineage and Cell class	DNAH3 DYNC2H1 DNAH2 TMEM232 ULK4 SPAG16 CFAP69	2.42e-06	193	138	7	0e37d454f3735edd936ee9a5f5f516ac3aad400e
ToppCell	Control-CD8+_T_naive\|Control / Disease condition and Cell class	EPHX2 THEMIS IMPDH2 OBSCN NBEA ATM FYB1	2.42e-06	193	138	7	627d345baf1940218c61907305705298e473dbab
ToppCell	IPF-Epithelial-Ciliated\|Epithelial / Disease state, Lineage and Cell class	DNAH3 DYNC2H1 DNAH2 TMEM232 ULK4 SPAG16 CFAP69	2.42e-06	193	138	7	ad58f5080e0ba65c845056ea6b79037b636e9c64
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH3 DYNC2H1 DNAAF4 DNAH2 NBEA ULK4 CFAP69	2.50e-06	194	138	7	4a2c127c90d1fefe604fcb9e796577d21b489dd6
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC4A7 MYCBP2 DYNC2H1 USP9X ASH1L NBEA AFF4	2.59e-06	195	138	7	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC4A7 MYCBP2 DYNC2H1 USP9X ASH1L NBEA ABCA5	2.59e-06	195	138	7	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	IPF-Lymphoid-T\|Lymphoid / Disease state, Lineage and Cell class	THEMIS SLC4A7 DOCK9 MYO1B ANKRD55 RYR2 FYB1	2.68e-06	196	138	7	6e70c48a63d9673eb16b0847c1bd88eecc2f7a3c
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH3 DYNC2H1 DNAAF4 CEP290 DNAH2 ULK4 CFAP69	2.77e-06	197	138	7	74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9
ToppCell	(04)_Interm._basal>secr.-(2)_GFP_FOXI1\|(04)_Interm._basal>secr. / shred by cell type by condition	TANC2 BCLAF1 CD2AP CEP290 UBXN4 OSBPL1A NIPBL	2.96e-06	199	138	7	53ca3861f9e00dab3f3fbefb0837857ee39ab084
ToppCell	droplet-Liver-LIVER_HEP-30m-Myeloid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYCBP2 CD2AP CDK14 SERPINB10 PLEK FYB1	1.62e-05	172	138	6	3f784aed340b50ddbec3f7dc0a5279180d38a2bb
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TANC2 DSP NBEA CMYA5 TANC1 AFF4	2.03e-05	179	138	6	6e965e424eebef50f0202cff75f458be395cfca1
ToppCell	3'_v3-bone_marrow-Myeloid_Mac-Erythrophagocytic_macrophages\|bone_marrow / Manually curated celltypes from each tissue	PSD3 OAS1 OSBPL1A NAV1 HSD17B4 GGPS1	2.09e-05	180	138	6	daf69a548ed7c6f285a6adcff00f99aa22f9d6a5
ToppCell	droplet-Spleen-nan-18m\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYCBP2 CD2AP ASH1L RBM39 TOP2B AFF4	2.23e-05	182	138	6	eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c
ToppCell	droplet-Spleen-nan-18m-Lymphocytic\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYCBP2 CD2AP ASH1L RBM39 TOP2B AFF4	2.30e-05	183	138	6	28cbf909424f3be4491d49832f0aca0386560814
ToppCell	droplet-Spleen-nan-18m-Lymphocytic-nan\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYCBP2 CD2AP ASH1L RBM39 TOP2B AFF4	2.30e-05	183	138	6	3fa608aa6b119869ec3280dc388dfee57160e63a
ToppCell	NS-critical-d_16-33-Epithelial-Ciliated\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DNAH3 DYNC2H1 DNAAF4 DNAH2 TMEM232 CFAP69	2.52e-05	186	138	6	76033438426d8f9c72cd6691a7baf92104c9f03d
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	TANC2 CDKL2 DOCK9 DNAH14 OSMR WWC1	2.52e-05	186	138	6	acfa68a2afb7d2b51c9b469a1965fe5cc5d5e64e
ToppCell	droplet-Bladder-nan\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYCBP2 ASH1L RBM39 UBXN4 MORF4L1 NIPBL	2.59e-05	187	138	6	663991a8afe652e92363b64bcbd68c14d0307f0e
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TANC2 SLC4A7 DNAH14 STOX2 SPAG16 WWC1	2.59e-05	187	138	6	c31130fc2f9f882944b2ba366a034a03f051c4b9
ToppCell	LA-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	MYOM3 OBSCN PSD3 CMYA5 RYR2 TANC1	2.67e-05	188	138	6	6d249fe92d51a19da19ec14bb2262d394255d577
ToppCell	(1)_T_CD4_naive\|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)	EPHX2 THEMIS ASH1L ANKRD55 ATM FYB1	2.67e-05	188	138	6	b8f67ac2faadd5b848955e43ab5d6cf5e49b3681
ToppCell	droplet-Tongue-nan\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ASH1L RBM39 UBXN4 CMIP SEC62 NIPBL	2.67e-05	188	138	6	d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TANC2 SLC4A7 DNAH14 STOX2 SPAG16 WWC1	2.67e-05	188	138	6	af740fa78542438fdff627ea1f74f4eee43316be
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2-D175\|Adult / Lineage, Cell type, age group and donor	TANC2 DOCK9 ARMC9 DNAH14 C5 WWC1	2.67e-05	188	138	6	ec38def1fdbb34ed9b30244806975bd5a4370164
ToppCell	RV-15._Ventricular_Cardiomyocyte_III\|World / Chamber and Cluster_Paper	OBSCN PSD3 CMYA5 RYR2 STOX2 TANC1	2.75e-05	189	138	6	0a82931b5f6c0a6427ca3edd5e2235ac49099d40
ToppCell	COPD-Epithelial-Ciliated\|Epithelial / Disease state, Lineage and Cell class	DNAH3 DYNC2H1 DNAH2 TMEM232 ULK4 SPAG16	2.75e-05	189	138	6	3e77883db34722b9ce0a03ea74caefc92dc7feff
ToppCell	RV-15._Ventricular_Cardiomyocyte_III\|RV / Chamber and Cluster_Paper	OBSCN PSD3 CMYA5 RYR2 STOX2 TANC1	2.84e-05	190	138	6	93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b
ToppCell	COVID-19-Heart\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MYOM3 OBSCN PSD3 CMYA5 RYR2 NAV1	2.84e-05	190	138	6	918ad5037881212008f9f69d5df5da91fd01422c
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	EPHX2 THEMIS DOCK9 TRAPPC13 ATM FYB1	2.92e-05	191	138	6	d9a6f61fcda4f5352488f7f55cb9b57aeacc717f
ToppCell	LA-03._Atrial_Cardiomyocyte\|LA / Chamber and Cluster_Paper	MYOM3 OBSCN PSD3 CMYA5 RYR2 TANC1	2.92e-05	191	138	6	5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TANC2 SLC4A7 UBAP1 DNAH14 SHISA9 WWC1	2.92e-05	191	138	6	9032aa974aa1b7b1095b8d1b58dcb087358a5001
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TANC2 SLC4A7 UBAP1 DNAH14 SHISA9 WWC1	2.92e-05	191	138	6	5717809a1476c20f65bce722c5a57cff92ee0d7a
ToppCell	nucseq-Epithelial-Epithelial_Airway\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DNAH3 DYNC2H1 DNAH2 TMEM232 SPAG16 CFAP69	2.92e-05	191	138	6	1c528f72c9ef3ef3a850b05e4a9715190832270c
ToppCell	E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-matrix_-_mature\|E16.5-samps / Age Group, Lineage, Cell class and subclass	ATP6V1A THEMIS CEP290 PSD3 CMYA5	2.96e-05	115	138	5	c3f6efb90d5ee01af831f65e240505faa6a71dc0
ToppCell	Control-Multiplet-Multiplet\|World / Disease state, Lineage and Cell class	DOCK9 MYO1B STOX2 TANC1 OSMR WWC1	3.01e-05	192	138	6	1bfd022d5b87cf8a5d5069f559339a553a52a0a2
ToppCell	COPD-Epithelial\|COPD / Disease state, Lineage and Cell class	MYO1B TMEM232 TANC1 OSMR CFAP69 WWC1	3.01e-05	192	138	6	0644fad5df18f0021f6f49cca996d8cf47f972ff
ToppCell	IPF-Epithelial-Ciliated\|IPF / Disease state, Lineage and Cell class	DNAH3 DYNC2H1 DNAH2 TMEM232 SPAG16 CFAP69	3.01e-05	192	138	6	354adc1354bf596fbc60dd45c0169688e6f45165
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	ZNF148 BCLAF1 USP9X CD2AP CKAP5 CRYBG3	3.10e-05	193	138	6	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	NS-critical-d_07-13-Epithelial-Ciliated\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DNAH3 DYNC2H1 DNAAF4 DNAH2 TMEM232 CFAP69	3.19e-05	194	138	6	1ae8a10e508e672e6677f0e3c986ac30d05adeb3
ToppCell	RA-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	OBSCN PSD3 CMYA5 RYR2 ULK4 TANC1	3.19e-05	194	138	6	89812fb164065041357bb37a3c2d87028ec3de4e
ToppCell	RA-03._Atrial_Cardiomyocyte\|RA / Chamber and Cluster_Paper	MYOM3 OBSCN PSD3 CMYA5 RYR2 TANC1	3.19e-05	194	138	6	c3535f7cc0076653c72db582047cff053c322397
ToppCell	Control-Multiplet\|Control / Disease state, Lineage and Cell class	DOCK9 MYO1B STOX2 TANC1 OSMR WWC1	3.28e-05	195	138	6	618900c80bea09d46dad3f741bd1bff8bf0a64ee
ToppCell	IPF-Multiplet-Multiplet\|World / Disease state, Lineage and Cell class	DNAH3 DYNC2H1 TMEM232 SPAG16 CFAP69 WWC1	3.28e-05	195	138	6	21dbdc803c6947024dc2416e9e21c2ef0af9bc31
ToppCell	Control-Multiplet-Multiplet\|Control / Disease state, Lineage and Cell class	DOCK9 MYO1B STOX2 TANC1 OSMR WWC1	3.28e-05	195	138	6	06ac685855e14e4dd2cbe6d0e73f894f2eeff91f
ToppCell	Control-Lymphoid-T\|Lymphoid / Disease state, Lineage and Cell class	THEMIS SLC4A7 DOCK9 ANKRD55 RYR2 FYB1	3.28e-05	195	138	6	6687e579582d7a239bee80846de0cf827a6f6a62
ToppCell	moderate-Epithelial-Ciliated\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	DNAH3 DYNC2H1 DNAAF4 DNAH2 TMEM232 CFAP69	3.28e-05	195	138	6	3486eae5fdb062a75a907b896c9d7b396d2aa195
ToppCell	moderate-Epithelial-Ciliated\|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	DNAH3 DYNC2H1 DNAAF4 DNAH2 TMEM232 CFAP69	3.28e-05	195	138	6	e80f5cdf0b18066b3e6c2f5452e58f101c67932c
ToppCell	COVID-19-Epithelial-Ciliated_cells\|Epithelial / Condition, Lineage and Cell class	DNAH3 DYNC2H1 DNAAF4 DNAH2 SPAG16 CFAP69	3.38e-05	196	138	6	de7aa31354b019d7321a8ef965d59ce2e8b89276
ToppCell	critical-Epithelial-Ciliated\|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	DNAH3 DYNC2H1 DNAAF4 DNAH2 TMEM232 CFAP69	3.38e-05	196	138	6	27b855c6e1ae44f16db998cf0e81bd686b9cee7e
ToppCell	COPD-Multiplet-Multiplet\|COPD / Disease state, Lineage and Cell class	DNAH3 TMEM232 TANC1 OSMR CFAP69 WWC1	3.38e-05	196	138	6	af4cdc61830685a888a1209826c23bcf54a43084
ToppCell	COPD-Multiplet\|COPD / Disease state, Lineage and Cell class	DNAH3 TMEM232 TANC1 OSMR CFAP69 WWC1	3.38e-05	196	138	6	6d02d494196e3f857d53eea46d9419690d43beca
ToppCell	NS-control-d_0-4-Epithelial-Ciliated\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DNAH3 DYNC2H1 DNAAF4 DNAH2 TMEM232 CFAP69	3.38e-05	196	138	6	d46ab80554dd3c1cc81e1938ea2acfd5e85c6d2a
ToppCell	IPF-Epithelial\|IPF / Disease state, Lineage and Cell class	DNAH3 DYNC2H1 TMEM232 SPAG16 CFAP69 WWC1	3.38e-05	196	138	6	87d9881cfec461a5d89b688a83749b618c519485
ToppCell	COPD-Lymphoid-T\|Lymphoid / Disease state, Lineage and Cell class	THEMIS SLC4A7 MYO1B ANKRD55 RYR2 FYB1	3.38e-05	196	138	6	c9bdd505c3ab380ed7b272aa518df31a0a706a06
ToppCell	healthy_donor-Lymphocytic-T_cell-CD4+_Naive_T_cell\|healthy_donor / Disease condition, Lineage, Cell class and subclass	EPHX2 DOCK9 OBSCN ANKRD55 ATM FYB1	3.47e-05	197	138	6	cf72160f03105876641fa6fdc7405e339eb084c7
ToppCell	Control-Classical_Monocyte-cMono_2\|Classical_Monocyte / Disease condition and Cell class	BCLAF1 CANX RBM39 RTRAF PLEK FYB1	3.47e-05	197	138	6	eb7610c9496a95a5fd866e16abcbc39b83abe617
ToppCell	critical-Epithelial-Ciliated\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	DNAH3 DYNC2H1 DNAAF4 DNAH2 TMEM232 CFAP69	3.57e-05	198	138	6	ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40
ToppCell	Bronchial-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CDKL2 MYO1B DNAH14 STOX2 WWC1 LRP2BP	3.67e-05	199	138	6	5f7da3eab58ace6cddb3179a415cd839d5767958
ToppCell	Bronchial-NucSeq-Epithelial-Epi_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CDKL2 MYO1B DNAH14 STOX2 WWC1 LRP2BP	3.67e-05	199	138	6	725610310e5c5fd7120c0be9acb55bf152026ddd
ToppCell	(10)_Ciliated-(2)_GFP_FOXI1\|(10)_Ciliated / shred by cell type by condition	BCLAF1 CD2AP CEP290 MRPL45 UBXN4 NIPBL	3.67e-05	199	138	6	61b1ed2db71b96157b92b7535d1955a4033098da
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TANC2 CDKL2 MYO1B DNAH14 STOX2 WWC1	3.67e-05	199	138	6	8587bd98de7767a575088afbea07a1feb4516b9b
ToppCell	(00)_Basal-(2)_GFP_FOXI1\|(00)_Basal / shred by cell type by condition	BCLAF1 MRPL45 UBXN4 RTRAF FYB1 NIPBL	3.67e-05	199	138	6	19674e1eaeb51e4196d847cb62aa437c852951d3
ToppCell	human_hepatoblastoma-Tumor_cells-T9\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	NUCB1 PGK1 SCYL2 FGD6 AFF4 WWC1	3.67e-05	199	138	6	e9c83555d2197b740797a9f33b64f8f7a7ba1ee2
ToppCell	LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_only / Treatment groups by lineage, cell group, cell type	DSP CD2AP CEP290 SYTL5 C5 WWC1	3.78e-05	200	138	6	2dadf317a42a7e27cc1fac74f91b806c93a57108
ToppCell	mLN-Macrophage-LYVE1_Macrophage\|Macrophage / Region, Cell class and subclass	USP9X RBM39 UBXN4 ATG3 CDC16 PNPLA8	3.78e-05	200	138	6	e3c15e0e1c2602b0cc9ab8cc50c978d265350c94
ToppCell	Bronchus_Control_(B.)-Epithelial-TX-Basal_3\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	IMPDH2 DSP SHB MYO1B SERPINB5 OSMR	3.78e-05	200	138	6	06b59ee536414d1f73c1e17cdfd7c3f2259b9bef
ToppCell	COVID-19\|World / Disease, condition lineage and cell class	MYCBP2 BCLAF1 RBM39 PIM3 NIPBL AFF4	3.78e-05	200	138	6	7dec470c379cd89f05a0f37c8628b21f136e52f0
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	THEMIS DNAH2 UBXN4 ATM FYB1	4.08e-05	123	138	5	511b7c20a4a85e49980936d52af7dbca19bb848e
ToppCell	COVID-19-Epithelial_cells-Airway_mucous\|COVID-19 / group, cell type (main and fine annotations)	DNAH3 DSP SERPINB5 TMEM232 SPAG16	1.08e-04	151	138	5	8216462e723fec2797387929dde095370947e10a
ToppCell	CV-Healthy-3\|Healthy / Virus stimulation, Condition and Cluster	CD2AP ASH2L PITPNA NAV1 CRYBG3	1.18e-04	154	138	5	26bf81a86700db7e65c2384ffe94ed4253ea4047
ToppCell	Control-Epithelial_alveolar-AT_2-Differentiating_AT1\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DSP MRPL45 LARS2 MIGA2 PLEK	1.29e-04	157	138	5	4766f7d545bf2d775390589460677519cb92f4d5
ToppCell	Control-B_naive-12\|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5)	DOCK9 MYO1B LARS2 CRYBG3 FYB1	1.33e-04	158	138	5	41318f864770370ce77ed3fa4a84f76c0c22c482
ToppCell	10x5'-GI_large-bowel-Lymphocytic_T_CD4-Tregs\|GI_large-bowel / Manually curated celltypes from each tissue	EPHX2 CDKL2 NAB1 ANKRD55 FYB1	1.50e-04	162	138	5	9a5e65c45f73a6a685b8362aa2e6aea77181caa3
ToppCell	droplet-Kidney-nan-24m-Myeloid-nan\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DNAH2 CMYA5 SERPINB10 PLEK FYB1	1.73e-04	167	138	5	2ee1660be117e20f24557522345572d11cbee813
ToppCell	PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_G2M\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ZDHHC2 CKAP5 SERPINB5 SGO2 FYB1	1.73e-04	167	138	5	d21635df8b74189e3309eaf435af381fbe412574
ToppCell	droplet-Kidney-nan-3m-Lymphocytic-CD45____T_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZDHHC2 THEMIS CPNE6 SERPINB5 FYB1	1.83e-04	169	138	5	3c4c3279cd72f39b5e7ff77741950ed3873c0317
ToppCell	5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH3 DYNC2H1 TMEM232 ULK4 CFAP69	1.83e-04	169	138	5	fba841664939c771881ba97f14ef1df6635c04ff
ToppCell	PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_prolif\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DOCK9 TOPBP1 MAP10 TANC1 CRYBG3	1.83e-04	169	138	5	8a6d05b5d60b2b2e43a8ff7521feb79cd6dbd940
ToppCell	droplet-Kidney-nan-3m-Lymphocytic-T_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZDHHC2 THEMIS CPNE6 SERPINB5 FYB1	1.83e-04	169	138	5	d6437afa298c280d202ba686338c6d8a37bd7ab7
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH3 DYNC2H1 DNAH2 NBEA CFAP69	1.83e-04	169	138	5	14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f
ToppCell	droplet-Marrow-nan-3m-Myeloid-monocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYCBP2 CD2AP MIA2 NAV1 FYB1	1.93e-04	171	138	5	992df143d76f9e7fb1997a8996f61e941f0f9d4f
ToppCell	T_cells-CD56_bright_CD16-_NK_cells\|World / Immune cells in Kidney/Urine in Lupus Nephritis	DSG1 DNAH14 RYR3 MIA2 SYTL5	1.98e-04	172	138	5	980e8b9e1ceeb0dec9eb9ef95c139e5ffe99b6e4
ToppCell	TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Non-keratinizing_Cervical_Squamous_Cell_Carcinoma-3\|TCGA-Cervix / Sample_Type by Project: Shred V9	ATP6V1A MYCBP2 SERPINB5 CMIP CRYBG3	2.15e-04	175	138	5	0cc215109d9915af47e4d0a120ce2e46910715fa
ToppCell	facs-Marrow-T_cells-18m-Myeloid-CD4+_macrophage\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD2AP OBSCN CMYA5 ANKRD55 ABCA5	2.20e-04	176	138	5	74f851a398c7562dd713bc0d8d488c0037243112
ToppCell	droplet-Heart-nan-3m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CKAP5 CMYA5 RYR2 PNPLA8 TOP2B	2.20e-04	176	138	5	749b47eac5436fa34e0d243ffbc6f1897f4e431e
ToppCell	facs-Marrow-T_cells-18m-Myeloid-macrophage\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD2AP OBSCN CMYA5 ANKRD55 ABCA5	2.20e-04	176	138	5	31b5459a978d5cdde0af03a77401e0464d8c95ba
Drug	1 mN-9	IMPDH1 IMPDH2 PGK1 PGK2	2.56e-07	10	137	4	CID000122108
Drug	Crotamiton [483-63-6]; Down 200; 19.6uM; MCF7; HT_HG-U133A	EPHX2 ATP6V1A SLC4A7 BAZ1B MYO1B PRUNE1 ARHGAP1 ATM OSMR	1.42e-06	179	137	9	3388_DN
Drug	terpentecin	ZDHHC2 GGPS1 TOP2B	7.33e-06	7	137	3	CID000127568
Drug	AC1LALA3	ATP6V1A DSG1 ASH1L PSD3	3.04e-05	30	137	4	CID000490573
Drug	hydroxymethylphosphonate	IMPDH1 IMPDH2	3.59e-05	2	137	2	CID000075795
Drug	4-Arsono-2-hydroxybutanoic acid	PGK1 PGK2	3.59e-05	2	137	2	CID000135804
Drug	6-Chloropurine Riboside, 5'-Monophosphate	IMPDH1 IMPDH2	3.59e-05	2	137	2	DB03948
Drug	Mycophenolate mofetil	IMPDH1 IMPDH2	3.59e-05	2	137	2	DB00688
Drug	purinogen	IMPDH1 IMPDH2	3.59e-05	2	137	2	CID003081226
Drug	AC1L9X6T	IMPDH1 IMPDH2	3.59e-05	2	137	2	CID000477594
Drug	Mycophenolic acid	IMPDH1 IMPDH2	3.59e-05	2	137	2	DB01024
Disease	Gonadal dysgenesis XX type deafness	LARS2 SGO2 HSD17B4	3.09e-06	7	133	3	C0685838
Disease	Severe dermatitis, multiple allergies, metabolic wasting syndrome	DSG1 DSP	2.02e-05	2	133	2	C3809719
Disease	pulse pressure measurement	SLC4A7 PDPR DYNC2H1 NAB1 TTI2 SHB CKAP5 UBAP1 NBEA UPF3A CDK14 SUCLA2 CDC16 MORF4L1 NAV1 ULK4 CFAP69 FGD6	5.52e-05	1392	133	18	EFO_0005763
Disease	congenital myopathy 1A (implicated_via_orthology)	RYR2 RYR3	6.03e-05	3	133	2	DOID:3529 (implicated_via_orthology)
Disease	malignant hyperthermia (implicated_via_orthology)	RYR2 RYR3	6.03e-05	3	133	2	DOID:8545 (implicated_via_orthology)
Disease	Striate palmoplantar keratoderma	DSG1 DSP	6.03e-05	3	133	2	C4707237
Disease	Perrault syndrome (is_implicated_in)	LARS2 HSD17B4	2.00e-04	5	133	2	DOID:0050857 (is_implicated_in)
Disease	cancer (implicated_via_orthology)	PIP5K1C PGK1 PGK2 PROX2 ATM NIPBL TOP2B	2.22e-04	268	133	7	DOID:162 (implicated_via_orthology)
Disease	diastolic blood pressure, systolic blood pressure	SLC4A7 DYNC2H1 CANX DNAH2 ARMC9 RYR2 CMIP PITPNA NAV1 FOLH1B ULK4	2.35e-04	670	133	11	EFO_0006335, EFO_0006336
Disease	Perrault syndrome	LARS2 HSD17B4	2.99e-04	6	133	2	cv:C0685838
Disease	pyoderma gangrenosum	SERPINB5 HSD17B4	7.11e-04	9	133	2	EFO_0006835
Disease	arrhythmogenic right ventricular cardiomyopathy (is_implicated_in)	DSP RYR2	8.86e-04	10	133	2	DOID:0050431 (is_implicated_in)
Disease	lung adenocarcinoma	EPHX2 COPS2 UBXN4 MORF4L1 ATM	1.18e-03	174	133	5	EFO_0000571
Disease	developmental disorder of mental health (implicated_via_orthology)	TANC2 ASH1L TANC1	1.42e-03	49	133	3	DOID:0060037 (implicated_via_orthology)
Disease	Malignant mesothelioma	RYR2 OSMR FGD6 WWC1	1.52e-03	109	133	4	C0345967
Disease	nodular sclerosis Hodgkin lymphoma	THEMIS UPF3A	1.77e-03	14	133	2	EFO_0004708
Disease	Hypertrophic Cardiomyopathy	DSP OBSCN RYR2	2.19e-03	57	133	3	C0007194
Disease	Leber congenital amaurosis	IMPDH1 CEP290	2.32e-03	16	133	2	cv:C0339527
Disease	Adenocarcinoma of lung (disorder)	SLC4A7 IMPDH2 SCYL2 EIF2B1 ATM	2.47e-03	206	133	5	C0152013
Disease	unipolar depression, response to bupropion, mood disorder	STOX2 FYB1	3.28e-03	19	133	2	EFO_0003761, EFO_0004247, EFO_0006326
Disease	leukemia (implicated_via_orthology)	ASH1L ATM	3.28e-03	19	133	2	DOID:1240 (implicated_via_orthology)
Disease	susceptibility to mononucleosis measurement	DNAH2 RYR2 CMIP	3.78e-03	69	133	3	EFO_0008403
Disease	chemokine (C-C motif) ligand 27 measurement	SLC4A7 UBAP1 ARMC9	3.93e-03	70	133	3	EFO_0008082
Disease	venous thromboembolism, plasminogen activator inhibitor 1 measurement	CKAP5 PLEK	4.00e-03	21	133	2	EFO_0004286, EFO_0004792
Disease	TNF-related apoptosis-inducing ligand measurement	DSG1 NDUFAF4 FOLH1B	4.26e-03	72	133	3	EFO_0008300
Disease	Leber Congenital Amaurosis	IMPDH1 CEP290	4.39e-03	22	133	2	C0339527

Protein segments in the cluster

Peptide	Gene	Start	Entry
ESFSSILAYKIPKED	ABCA5	1561	Q8WWZ7
DPSKLYKKADDVAAI	ASH1L	141	Q9NR48
YYNSKALKEDDPKAA	COPS2	36	P61201
PKDTDQYFETKAKKL	CRYBG3	556	Q68DQ2
DELVKKYSLPSKFSD	BAZ1B	276	Q9UIG0
KLSADTYEDLKAKLP	CMIP	746	Q8IY22
FKKKTSDNSKYLLPE	ANKRD55	406	Q3KP44
SPKFGKADSYEKLEK	CDK14	126	O94921
AAEKKYFSLKPEEKD	CD2AP	356	Q9Y5K6
YFSLKPEEKDEKSTL	CD2AP	361	Q9Y5K6
PSFKTFAYLAAKLDK	CASP8AP2	1946	Q9UKL3
AKDAKSVASDVPLYK	ASXL1	436	Q8IXJ9
AEYLTPVLKESKFKE	ATG3	16	Q9NT62
AEPYKVTSKEDKLSS	AFF4	36	Q9UHB7
TSEEESFYKKLLPFK	CCNB3	611	Q8WWL7
TETAKSLPDTYKDKA	ASH2L	496	Q9UBL3
SLPDTYKDKALIKFK	ASH2L	501	Q9UBL3
YKLDNKDLFSKSDPF	CPNE6	161	O95741
KKELDYFAKALENPV	PGK2	191	P07205
VYDITKKETFDDLPK	RAB12	121	Q6IQ22
DTKKDKHPDPYEFLL	SEPTIN14P20	41	C0HM01
EDLEKLFSKYGPLSE	RBM19	416	Q9Y4C8
LEAPYKKDENKLSSA	RBM39	11	Q14498
DPYKSSILSLIKFKE	OSMR	776	Q99650
SKDYKAEEDPAKFKS	PITPNA	151	Q00169
FYLPAKKNVDSILED	MORF4L1	221	Q9UBU8
TPKDSKYVEKLEALF	PRUNE1	191	Q86TP1
DFPALLSKAKKYLIA	FHIP1B	816	Q8N612
KRFYEKAEESKLPEI	OGFOD1	326	Q8N543
LYRTEDKKSPESSAK	MAP10	426	Q9P2G4
SSSKYDPEILKAEIA	WWC1	151	Q8IX03
DYPHSAFTLEKKVIK	NAB1	466	Q13506
KFKEKLDKASFATPY	ASMTL	41	O95671
PDKEELDEKISYFKT	ARMC9	116	Q7Z3E5
DLKKNRDYPLASKDA	IMPDH2	226	P12268
LSFKDAKLSVVEYDP	CPSF1	96	Q10570
VPDKFKYKADTLKVA	EIF2B1	246	Q14232
DLLALEQSKTFYKPD	PDPR	491	Q8NCN5
YDSLKLKKDSLGAPS	FYB1	571	O15117
YDALFDIESKVDPSK	FOLH1B	401	Q9HBA9
LKSEEDSSYKPVKKA	NIPBL	1956	Q6KC79
KYSPSESAKVYDKAI	NIPBL	2566	Q6KC79
LYYSTKEPKELEKAF	LRP2BP	181	Q9P2M1
TKAEKSPKGFLESYE	MIGA2	386	Q7L4E1
FSDYKEDLKPLLNTL	GGPS1	166	O95749
SSLEEPDFYKTKIKL	IL12A	181	P29459
KKELNYFAKALESPE	PGK1	191	P00558
NTPAKSLDKFIEDYL	OAS1	6	P00973
ADKEDLSDKLIPLFY	OR2S2	271	Q9NQN1
EALFTKELEKVYDPK	NUCB1	266	Q02818
SVDPATFDAYKKNDK	OSBPL1A	781	Q9BXW6
KKLADISLGKESYPD	DSG1	756	Q02413
DLKKNRDYPLASKDS	IMPDH1	226	P20839
LSQEKVLPSDKFKDY	OBSCN	7816	Q5VST9
KLDSDIPEIFKSSSY	PROX2	576	Q3B8N5
DTNADPKIKDYKLFK	CDKL2	341	Q92772
YVLKKPEDLTADDFS	DYNC2H1	2241	Q8NCM8
SKDASYTKALKLFED	ATM	1691	Q13315
KYLKDESGFKDPSSD	CDC16	106	Q13042
ILSKLPKDFYDKIEA	CKAP5	276	Q14008
SYKSKAPSLLFNLKD	CEFIP	491	Q711Q0
AKKYDFPIPLNEASK	C5orf47	116	Q569G3
YKFLLDTLKASPSEV	EPHX2	166	P34913
FYKDEKISKEPKGSI	DOCK9	216	Q9BZ29
SKEKKPSESDLERYY	DNAH3	221	Q8TD57
ALEKQFSKDTYSKPS	CEP290	2031	O15078
KDPKDLKFIYEGSSD	HSD17B4	356	P51659
KSEKLKDLFDYSPPL	BCLAF1	501	Q9NYF8
DATISIKSYPDKKFS	C5	51	P01031
KLEYLEEKASFKTIP	CMYA5	2976	Q8N3K9
ASASPKEKYSLVEAK	DSP	2021	P15924
RPDADLKTYFTDKKT	CANX	221	P27824
YASEKTSPKRELAKD	C17orf80	141	Q9BSJ5
PKAKKSKEISYNLED	DNAH14	591	Q0VDD8
LEPDSLAKVTYDFDK	DNAH14	1796	Q0VDD8
AFLYAPIDDESSKAK	DNAAF4	51	Q8WXU2
PEDKAKYDAIFDSLS	EPS15	126	P42566
SPAEKAKYDEIFLKT	EPS15	221	P42566
EPVKYPDKFSQASKD	GRK1	411	Q15835
PFLKKKVSDEITYAE	CFAP69	121	A5D8W1
FLKEPKVYEDLTDLT	DNAH2	2696	Q9P225
LVPYDTLTAKEKAKD	RYR2	2871	Q92736
SYFPKKISELDAFLK	PSME1	31	Q06323
KPFSLTKDVLLDVAY	TBRG4	286	Q969Z0
EKTDESDTIPYLKKF	MIA2	446	Q96PC5
IAYLKPKSESSIEKD	OR10J5	256	Q8NHC4
SLKKYSDKSAEKSPF	PNPLA8	156	Q9NP80
SEEKAPKKLEYDSGS	NAV1	476	Q8NEY1
LFSELPLAKKKETYD	MRPS33	36	Q9Y291
AEKYKDLVPDNSKTA	RTRAF	96	Q9Y224
FVKGYLLPDDSKATK	SYTL5	611	Q8TDW5
DKPALSKTEDRKEYN	USP9X	1626	Q93008
VLADLAIYEPKTFKS	MRPL20	101	Q9BYC9
AIYEPKTFKSLAALA	MRPL20	106	Q9BYC9
KISFEDEPRKKYVDA	SLC4A7	1196	Q9Y6M7
KKDKVTIADDYSDPF	SHB	236	Q15464
YSDPFDAKNDLKSKA	SHB	246	Q15464
LDKDEYTFSPGKSKA	TOP2B	1416	Q02880
ASKISEADKSKPKFY	LARS2	71	Q15031
KDYDANFKIKDFPEK	MRPL45	126	Q9BRJ2
AKTGSIEDDPEYKKF	UPF3A	166	Q9H1J1
KEKEKSFPTYKDLDF	PIP5K1C	266	O60331
DGIEFYKKKSDNSPK	PLEK	31	P08567
YKETPAAFPDTIKEK	NBEA	1641	Q8NFP9
LKYDDFLKSTQKSPA	ARHGAP1	211	Q07960
SPKADKVNDDFYTKR	SHISA9	296	B4DS77
LEKDNFFSLTPKDKE	SGO2	836	Q562F6
SPDIKDYKLYDVETK	SCYL2	141	Q6P3W7
EEFASKALELKPKSY	TANC1	1356	Q9C0D5
EEFATKALELKPKSY	TANC2	1311	Q9HCD6
PYAKELETVDFKDKL	SERPINB5	111	P36952
SDSYTLDPDTLRKKK	MYCBP2	2871	O75592
LLSFLKDVYVDSKDP	NDUFAF4	61	Q9P032
LEIFLSEKKSISYPA	OR5M8	81	Q8NGP6
VAKSPDEAYAIAKKL	SUCLA2	76	Q9P2R7
SSKLAYPEVEESKFK	SLC28A2	376	O43868
DDKPPSKKSFFYKEV	AKAP3	231	O75969
NYKPTFLSDDELKHL	ARNTL	136	O00327
SLFDYLHPKDIAKVK	ARNTL	191	O00327
YASPENKKLFEEEKL	MRPL9	131	Q9BYD2
TAYDLEIAKSEKEPL	THEMIS	351	Q8N1K5
KKLLKEYYSTESEPL	UHRF1BP1L	766	A0JNW5
KPKDFKTEEELLSYI	TICRR	631	Q7Z2Z1
YLDDVPFKTGDKFKT	UBAP1	16	Q9NZ09
EPSKEEKAVAKYLRF	SEC62	16	Q99442
AKALEKYAAPSKEEE	TTI2	86	Q6NXR4
DFTSLSKDELLYKPD	SAGE1	766	Q9NXZ1
LVPYDTLTAKEKFKD	RYR3	2766	Q15413
YPDFFTKADKELAKI	TMEM232	581	C9JQI7
FSYKTETLSKPKDSE	STOX2	246	Q9P2F5
SKESLSPAKFDYKLK	SPAG16	331	Q8N0X2
RDDKKDGLKFYTDPS	WASF3	141	Q9UPY6
KKAASEELLEKSSYP	FGD6	511	Q6ZV73
LPKILDEDKESTFGY	ATP6V1A	6	P38606
LQPAKADKESFEKAY	PIM3	26	Q86V86
YKFLESLLQKDPSEV	ZNFX1	146	Q9P2E3
DIGVEDKSSFKPYSK	ZNF503	166	Q96F45
FSKEKYILDSSPEKL	SH2D3C	186	Q8N5H7
PSKEFHLSYAEKDLL	ZDHHC2	81	Q9UIJ5
SDLKKDKNDYLPLYS	ZNF148	336	Q9UQR1
PLDVKTKFYNAESDL	TRAPPC13	171	A5PLN9
YKKKLLDLELAPSAS	UBXN4	376	Q92575
FKDDKLYDPEKGARS	PJA1	146	Q8NG27
KLFKPSFDVKDALAA	TOPBP1	831	Q92547
YKPEKALSEEDLKNA	PSD3	831	Q9NYI0
ALASKATDYEKKPNV	PSD3	851	Q9NYI0
YDPDVFKTKPAALKA	THEGL	436	P0DJG4
LPKFKLEDSYDLKST	SERPINB10	291	P48595
PTYSVDKLLFLKDQD	ULK4	446	Q96C45
PKQKFSEDLESYKIS	ZNF789	101	Q5FWF6
ELFKDKKALYPSSVG	MYO1B	946	O43795
LDPKDSDKGKYTLEI	MYOM3	1281	Q5VTT5